JACC-Cardiovascular Interventions

Papers
(The H4-Index of JACC-Cardiovascular Interventions is 54. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2020-04-01 to 2024-04-01.)
ArticleCitations
Drug-Coated Balloons for Coronary Artery Disease210
3-Year Outcomes of the ULTIMATE Trial Comparing Intravascular Ultrasound Versus Angiography-Guided Drug-Eluting Stent Implantation147
Alignment of Transcatheter Aortic-Valve Neo-Commissures (ALIGN TAVR)139
Indigo Aspiration System for Treatment of Pulmonary Embolism133
5-Year Outcomes After TAVR With Balloon-Expandable Versus Self-Expanding Valves122
Incidence, Predictors, and Implications of Permanent Pacemaker Requirement After Transcatheter Aortic Valve Replacement119
Coronary Cannulation After Transcatheter Aortic Valve Replacement116
Transfemoral Transcatheter Tricuspid Valve Replacement With the EVOQUE System112
ACTIVATION (PercutAneous Coronary inTervention prIor to transcatheter aortic VAlve implantaTION)106
Assessment of Vascular Dysfunction in Patients Without Obstructive Coronary Artery Disease102
Distal Radial Artery Approach to Prevent Radial Artery Occlusion Trial92
Effect of CYP2C19 Genotype on Ischemic Outcomes During Oral P2Y12 Inhibitor Therapy89
Drug-Coated Balloon Versus Drug-Eluting Stent for Small Coronary Vessel Disease85
Valve-in-Valve Transcatheter Aortic Valve Replacement Versus Redo Surgical Aortic Valve Replacement84
Transcatheter Aortic Valve Replacement in Bicuspid Versus Tricuspid Aortic Valves From the STS/ACC TVT Registry79
Clinical Outcomes Following Coronary Bifurcation PCI Techniques79
Reoperation After Transcatheter Aortic Valve Replacement77
Coronary Calcification and Long-Term Outcomes According to Drug-Eluting Stent Generation77
Early Multinational Experience of Transcatheter Tricuspid Valve Replacement for Treating Severe Tricuspid Regurgitation77
Principles of Intravascular Lithotripsy for Calcific Plaque Modification75
Transcatheter Aortic Valve Replacement in Low-Risk Patients With Symptomatic Severe Bicuspid Aortic Valve Stenosis74
Randomized Trial Comparing Standard Versus Ultrasound-Assisted Thrombolysis for Submassive Pulmonary Embolism73
Patient-Specific Implantation Technique to Obtain Neo-Commissural Alignment With Self-Expanding Transcatheter Aortic Valves72
Cardiopulmonary Hemodynamic Profile Predicts Mortality After Transcatheter Tricuspid Valve Repair in Chronic Heart Failure70
Conscious Sedation Versus General Anesthesia for Transcatheter Aortic Valve Replacement70
COAPT-Like Profile Predicts Long-Term Outcomes in Patients With Secondary Mitral Regurgitation Undergoing MitraClip Implantation69
Long-Term Outcomes of Coronary Stenting With and Without Use of Intravascular Ultrasound69
Randomized Comparison of Transcatheter Edge-to-Edge Repair for Degenerative Mitral Regurgitation in Prohibitive Surgical Risk Patients68
Impact of Left Ventricular Outflow Tract Calcification on Procedural Outcomes After Transcatheter Aortic Valve Replacement68
Suture- or Plug-Based Large-Bore Arteriotomy Closure68
Aspirin-Free Prasugrel Monotherapy Following Coronary Artery Stenting in Patients With Stable CAD68
Intravascular Lithotripsy for Treatment of Calcified Coronary Lesions67
Clinical Outcomes Associated With Left Atrial Appendage Occlusion Versus Direct Oral Anticoagulation in Atrial Fibrillation66
Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization66
Surgical Explantation After TAVR Failure65
Short Duration of DAPT Versus De-Escalation After Percutaneous Coronary Intervention for Acute Coronary Syndromes64
Triage Considerations for Patients Referred for Structural Heart Disease Intervention During the COVID-19 Pandemic64
Coronary Access After TAVR-in-TAVR as Evaluated by Multidetector Computed Tomography63
Intravascular Lithotripsy for Peripheral Artery Calcification62
Risk of Coronary Obstruction Due to Sinus Sequestration in Redo Transcatheter Aortic Valve Replacement62
Racial, Ethnic, and Sex Disparities in Patients With STEMI and Cardiogenic Shock62
Transcatheter Edge-to-Edge Mitral Valve Repair With the MitraClip G4 System62
Permanent Pacemaker Reduction Using Cusp-Overlapping Projection in TAVR61
The Impact of Coronary Physiology on Contemporary Clinical Decision Making61
Subclinical Leaflet Thrombosis After Transcatheter Aortic Valve Replacement60
Direct Oral Anticoagulants Versus Vitamin K Antagonists in Patients With Atrial Fibrillation After TAVR60
Arterial Lactate in Cardiogenic Shock60
1-Year Outcomes for Transcatheter Repair in Patients With Mitral Regurgitation From the CLASP Study58
3- or 1-Month DAPT in Patients at High Bleeding Risk Undergoing Everolimus-Eluting Stent Implantation57
Transfemoral Tricuspid Valve Replacement in Patients With Tricuspid Regurgitation57
Transcatheter Mitral Valve Repair in Cardiogenic Shock and Mitral Regurgitation55
Distal or Traditional Transradial Access Site for Coronary Procedures55
Clinical Characteristics and Outcomes of STEMI Patients With Cardiogenic Shock and Cardiac Arrest55
Preventing Coronary Obstruction During Transcatheter Aortic Valve Replacement54
0.28910899162292